Stocktoria

60 DEGREES PHARMACEUTICALS, INC. SXTP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-07-12

60 DEGREES PHARMACEUTICALS, INC. statistics & valuation

Market cap$4.3M
P / S4.3×
P / B1.2×
Net margin-732.5%
FCF margin-695.1%
Net cash$1.4M
Enterprise value USD$2.9M
Return on capital-220.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2769.50% -1485.10% -1308.00% -732.50% 2022202320242025
Gross margin (%)
-93.70% -87.10% 36.70% 22.30% 2022202320242025
Operating margin (%)
-784.20% -2032.80% -1599.00% -771.60% 2022202320242025
Return on equity (%)
-77.30% -196.90% -212.70% 2022202320242025
Shares outstanding
2.4M 96847 141749 1.2M 2022202320242025
Net debt ($)
$16.9M -$2.0M -$1.5M -$1.4M 2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-476.50% -48.40% -138.00% -137.30% 2022202320242025
Free cash flow margin (%)
-1814.30% -946.70% -695.10% 2022202320242025
Debt / equity (×)
0.03× 0.04× 0.04× 2022202320242025
EPS ($)
-$2.61 -$59.18 -$74.17 -$11.73 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin22.3%36.7%-87.1%-93.7%
Operating margin-771.6%-1599.0%-2032.8%-784.2%
Net margin-732.5%-1308.0%-1485.1%-2769.5%
FCF margin-695.1%-946.7%-1814.3%—
Return on assets-137.3%-138.0%-48.4%-476.5%
Return on equity-212.7%-196.9%-77.3%25.6%
Debt / equity0.04×0.04×0.03×-0.70×
Current ratio2.663.252.550.05

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.